United Kingdom · Biotechnology startup

Oxagen

Oxagen develops small molecule drugs to treat inflammatory and respiratory diseases.

Funding reportedLast round: Series C

BiotechnologyAbingdon, United Kingdom

What company datasets say Oxagen raised

Funding, as reported

Reported in all130.7Min the source's currency
Rounds3
Last roundSeries C
Last round size26.7M
Last round dateNov 2009
Investors listed19

The company, in detail

What they build

Known for

biotechnologylife sciences

Sector
Biotechnology
Region
England
Revenue
13.7M a year, as listed
Full record
Every detail in the company directory

Biotechnology in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Oxagen in front of investors. Or tell us what we have wrong.

List your startupSend a correction